| Identification | Back Directory | [Name]
EFLUCIMIBUM | [CAS]
202340-45-2 | [Synonyms]
L0081
L-0081
F12511
F-12511
eflucimibe
EFLUCIMIBUM
Benzeneacetamide, α-(dodecylthio)-N-(4-hydroxy-2,3,5-trimethylphenyl)-, (αS)- | [Molecular Formula]
C29H43NO2S | [MDL Number]
MFCD30533670 | [MOL File]
202340-45-2.mol | [Molecular Weight]
469.72 |
| Chemical Properties | Back Directory | [Boiling point ]
603.5±55.0 °C(Predicted) | [density ]
1.059±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
10.86±0.41(Predicted) | [color ]
Light brown to khaki |
| Hazard Information | Back Directory | [Uses]
Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis[1]. | [References]
[1] Nathalie Mesplet, et al. Analysis of eflucimibe and related impurities by highly sensitive liquid chromatography-electrospray-tandem mass spectrometry. The Journal of Separation Science. 2003. |
|
|